ClearPoint Neuro (CLPT) Enterprise Value (2011 - 2026)

ClearPoint Neuro has disclosed Enterprise Value across 16 years of filings, most recently posting -$35.6 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$35.6 million, down 187.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$35.6 million (down 187.4% YoY), and the FY2025 annual result was -$45.9 million, down 128.43% from the prior year.
• Enterprise Value came in at -$35.6 million for Q1 2026 at ClearPoint Neuro, up from -$45.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$12.4 million in Q1 2025 to a low of -$49.7 million in Q1 2022.
• The 5-year median for Enterprise Value is -$35.4 million (2024), against an average of -$33.1 million.
• Across the five-year window, Enterprise Value surged 65.01% in 2025 and tumbled 187.4% in 2026, its largest moves.
• ClearPoint Neuro's Enterprise Value stood at -$37.5 million in 2022, then surged by 38.32% to -$23.1 million in 2023, then advanced by 13.12% to -$20.1 million in 2024, then sank by 128.43% to -$45.9 million in 2025, then gained by 22.48% to -$35.6 million in 2026.
• The last three Enterprise Value figures came in at -$35.6 million (Q1 2026), -$45.9 million (Q4 2025), and -$38.2 million (Q3 2025), per Business Quant data.